CYPESTRA-35 drag 21 pce

7680572250022 CH-57225 G03HB01
CYPESTRA-35 drag 21 pce
CYPESTRA-35 drag 21 pce
CYPESTRA-35 drag 21 pce
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Articles (1)

Cypestra-35, Dragées
Dragées
21
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ethinylestradiolum
35.0 UG Substance Wirkstoff (Principe actif)
cyproteroni acetas
2.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
41.19 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
0.016 MM Substance HBESI
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 132
- Substance FIMDK
E 172 (flavum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 104
- Substance FIMDK
lacca
- Substance HNIDK
cera alba
- Substance HNIDK
cera carnauba
- Substance HNIDK
saccharum
10.36 MG Substance HBESI

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
57225
Drug name
Cypestra-35, Dragées
Galenic form
UEBT
ATC Code
G03HB01
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
14/06/2005
Authorization expiration date
01/07/2026
IT number
07.09.0.
Domain
Human medicine
Field of application
Androgenisierungserscheinungen

Packaging details

Description (FR)
CYPESTRA-35 drag 21 pce
Description (DE)
CYPESTRA-35 Drag 21 Stk
Market launch
14/06/2005
Market withdrawal
01/07/2026
Narcotic (BTM)
No

Other packaging sizes

CYPESTRA-35 drag 3 x 21 pce
3x21 DRG
View
Buy us a coffee Explore the data